Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Voshaar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|February 21, 2003
[Inhalation therapy: techniques and use of devices--main mistakes]Thomas Voshaar
Pneumologie (Stuttgart, Germany)|July 13, 2017
[Spacer, Aerosol Therapy through Space and Time]Thomas Voshaar, Peter Haidl, Rolf Michael Clös
Laryngo- Rhino- Otologie|December 7, 2019
[Spacer, Aerosol Therapy through Space and Time]Thomas Voshaar, Peter Haidl, Rolf Michael Clös
ERJ Open Research|June 24, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
ERJ Open Research|April 13, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
ERJ Open Research|March 19, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
Journal of Drug Assessment|August 19, 2016
Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrroniumPaul Colthorpe, Thomas Voshaar, Thomas Kieckbusch, et al.
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia begin?Dieter Köhler, Thomas Voshaar, Patrick Stais, et al.
COPD|December 11, 2020
Lung Deposition Using the Respimat<sup>®</sup> Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An <i>In Vitro</i>/<i>In Silico</i> AnalysisAnna-Maria Ciciliani, Mark Denny, Peter Langguth, et al.
Deutsches Arzteblatt International|May 25, 2016
The Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseAdrian Gillissen, Peter Haidl, Martin Khlhäufl, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Medizinische Klinik (Munich, Germany : 1983)|February 21, 2003
[Inhalation therapy: techniques and use of devices--main mistakes]Thomas Voshaar
Pneumologie (Stuttgart, Germany)|July 13, 2017
[Spacer, Aerosol Therapy through Space and Time]Thomas Voshaar, Peter Haidl, Rolf Michael Clös
Laryngo- Rhino- Otologie|December 7, 2019
[Spacer, Aerosol Therapy through Space and Time]Thomas Voshaar, Peter Haidl, Rolf Michael Clös
ERJ Open Research|June 24, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
ERJ Open Research|April 13, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
ERJ Open Research|March 19, 2021
Conservative management of COVID-19 associated hypoxaemiaThomas Voshaar, Patrick Stais, Dieter Köhler, et al.
Journal of Drug Assessment|August 19, 2016
Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrroniumPaul Colthorpe, Thomas Voshaar, Thomas Kieckbusch, et al.
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia begin?Dieter Köhler, Thomas Voshaar, Patrick Stais, et al.
COPD|December 11, 2020
Lung Deposition Using the Respimat<sup>®</sup> Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An <i>In Vitro</i>/<i>In Silico</i> AnalysisAnna-Maria Ciciliani, Mark Denny, Peter Langguth, et al.
Deutsches Arzteblatt International|May 25, 2016
The Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseAdrian Gillissen, Peter Haidl, Martin Khlhäufl, et al.
Pageof 2